Dr. Collin Y. Ewald

Dr. Collin Y. Ewald is a molecular biologist with over 20 years of research on the underlying mechanisms of aging. At institutions such as FMI, CUNY, Harvard, and ETH Zürich, Dr. Ewald has made scientific contributions to understanding the underlying molecular mechanisms of healthy aging and interventions slowing or preventing age-related pathologies.

Currently, Dr. Ewald serves as an Associate Director of Diseases of Aging and Regenerative Medicine (DARe) at the Novartis Biomedical Research. His research focuses on elucidating and target the molecular mechanisms underlying diseases of aging to develop regenerative pharmacological interventions for patients.

Dr. Ewald is the founder and president of the Swiss Society for Aging Research and the vice president of the German Society for Aging Research. He also holds a Lecturer/Docent position at ETH Zürich. His work has earned him numerous awards, including the NYAS Future Entrepreneur award from the New York Academy of Sciences. He is recognized as one of the top 1000 Longevity Leaders worldwide and one of Switzerland's Top 15 Longevity Influencers.